Two patterns of ion channelopathies relating to arrhythmias and direct and indirect blockade of ion channels by antiarrhythmic agents

Drug Development Research

Volumn 58, Issue 1, 2003, Pages 42-50

  Dai, De Zai ^a   Zhang, Guang Qin ^a   Yang, Ping ^a   Ma, Yu Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Arrhythmia; Cardiac remodeling; CPU 86017; Ion channels; L thyroxine; LQTS

Indexed keywords

ANTIARRHYTHMIC AGENT; BEPRIDIL; CPU 86017; LEVOTHYROXINE; POTASSIUM CHANNEL; PROPRANOLOL DERIVATIVE; SODIUM CHANNEL; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; BINDING KINETICS; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GENE INSERTION; GENE MUTATION; GENETIC POLYMORPHISM; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HEART REPOLARIZATION; IC 50; LIPID MEMBRANE; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; QT INTERVAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 0037282671     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10128     Document Type: Conference Paper

References (20)

1. An LF, Dai DZ. 1995. Liuwei Dihuang Decoction (LD) treated experimental arrhythmias and ventricular fibrillation induced by reperfusion and cardiomyopathy. Chin Tradit Med Clin 3:1-3.
2. Bennet PB, Yazawa K, Makita N, George AL Jr. 1995. Molecular mechanism for an inherited cardiac arrhythmia. Nature 376:683-685.
3. Curran ME, Splawski I, Timonthy KW, Vincent GM, Green ED, Keating MT. 1995. A molecular basis for cardiac arrhythmias: HERG mutations cause long QT syndrome. Cell 80:795-803.
4. Dai DZ. 2000. Vulnerable substrate and multiple ion channel disorder in a diseased heart will be new targets for antiarrhythmic therapy. Act Pharmacol Sin 21:289-295.
5. Dai DZ, Hu HJ, Yang DM, Hao XM, Zhang GQ, Zhou PE, Wu CH. 1999. Chronic levo-thyroxin treatment is associated with ion channel abnormalities in cardiac and neuron cell. Clin Exp Pharmacol Physiol 26:819-821.
6. Guerra PG, Talajic M, Roy D, Dubuc M, Thibault B, Nattle S. 1998. Is there a future for antiarrhythmic drug therapy? Drugs 56: 767-781.
7. K in acutely isolated hippocampal CA1 neurons. Brain Res 809:149-154.
8. 2+]i in rat ventricular myocytes following myocardial infarction. Cardiovasc Res 35:315-323.
9. Katz AM. 1998. Selectivity and toxicity of antiarrhythmic drugs: molecular interactions with ion channels. Am J Med 104:179-195.
10. Keating MT, Sanguinetti MC. 2001. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104:569-580.
11. Marban E. 2002. Cardiac channelopathies. Nature 45:213-218.
12. Meszaros J, Coutinho JJ, Bryant SM, Ryder KO, Hart G. 1997. L-type calcium current in catecholamine-induced cardiac hypertrophy in the rat. Exp Physiol 82:71-83.
13. Nabauer M, Kaab S. 1998. Potassium channel down-regulation in heart failure. Cardiovasc Res 37:324-334.
14. 2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res 37:300-311.
15. Roden DM, Balser JR, George AL Jr, Anderson ME. 2002. Cardiac ion channels. Annu Rev Physiol 64:431-475.
16. Sanguinetti MC, Curran ME, Zou A. 1996. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384:80-83.
17. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. 2001. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95
18. Splawski I, Tristanti-Fishman M, Lehmann MH, Sanginitti MC, Keating MT. 1997. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 388:289-292.
19. + currents in dogs with chronic complete atrioventricular block and acquired Torsades de pointes. Circulation 100:2455-2461.
20. Yu F, Dai DZ, An LF, Guo XF. 1997. Heart hypertrophy induced by levothyroxin aggravates ischemic lesions and reperfusion arrhythmias in rats. Act Pharmacol Sin 18:71-74.